90 Minutes of Knowledge, Empowerment: Webinar Summarizes Complex New SNF Rule

November 11, 2016
Spotlight

“We will highlight the major changes, including the timing of the adoption phases--the first of which starts on November 28 of this year," says Karl Steinberg, MD, CMD. "Then we will talk about the issues that have the greatest implication for and impact on medical directors and other clinicians." These include new definitions of psychotropic drugs and increased consultant pharmacist tasks. The presenters also will explain the QAPI process that facilities will be required to develop and describe the focus on antibiotic stewardship and infection control in the final rule.